Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran

Cancer

Volumn 82, Issue 9, 1998, Pages 1704-1708

  Offodile, Regina ^a   Hoh, Carl ^a   Barsky, Sanford H ^a   Nelson, Scott D ^a   Elashoff, Robert ^a   Eilber, Frederick R ^a   Economou, James S ^a   Nguyen, Mai ^a,b  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Axillary lymph node dissection; Breast carcinoma; Sentinel lymph node; Staging

Indexed keywords

DEXTRAN TC 99M;

ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER STAGING; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; MINIMALLY INVASIVE SURGERY; PRIORITY JOURNAL;

BREAST NEOPLASMS; DEXTRANS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS;

EID: 0032080469     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980501)82:9<1704::AID-CNCR17>3.0.CO;2-8     Document Type: Article

References (17)

1. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerman L, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989;320:822-8.
2. Chassin JL. Axillary lymphadenectomy. In: Chassin JL. Operative strategy in general surgery. New York: Springer Verlag, 1994:468-72.
3. Harris JR, Morrow M, Bonadonna G. Cancer of the breast. In: DeVita VT, Hellman S, Rosenberg SA. Cancer: principles and practice of oncology. 5th edition. Philadelphia: J. B. Lippincott, 1997:1557-616.
4. Alazraki NP, Eshima D, Eshima LA, Herda SC, Murray DR, Vansant JP, et al. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med 1997;27:55-67.
5. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
6. Henze E, Schelbert HR, Collins JD, Najafi A, Barrio JR, Bennett LR. Lymphoscintigraphy with Tc-99m-labelled dextran. J Nucl Med 1982;23:923-9.
7. Reintgen DS. Changing standards of surgical care for the melanoma patient. Ann Surg Oncol 1996;3:327-8.
8. Van der Veen H, Hoekstra OS, Paul MA, Cuesta MA, Meijer S. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 1994;81:1769-70.
9. Alex JC, Krag DN. Gamma probe-guided localization of lymph nodes. Surg Oncol 1993;2:137-43.
10. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
11. Giuliano AE, Dale PS, Turner RR, Morton DL. Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;3:394-401.
12. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15:2345-50.
13. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-40.
14. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1997;276:1818-22.
15. Veronisi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864-7.
16. Thompson L, Chang B, Barsky SH. Monoclonal origins of malignant mixed tumors (carcinosarcomas). Am J Surg Pathol 1996;20:277-85.
17. Cox C, Reintgen D. Lymphatic mapping and sentinel node biopsy in breast cancer. JAMA 1997;277:791-2.